Form D Explorer
Kestrel Therapeutics Inc. · CIK 1853373

Report a data issueCitable research briefCompare issuerPrivate research collection

Kestrel Therapeutics Inc.

CIK 1853373 · Corporation · Inc. DELAWARE · Boston, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Feb 21, 2025
through Aug 12, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldFeb 21, 2025 · DAug 12, 2025 · DLater minus earlier
Reported offering amount$16,000,000$10,000,000$-6,000,000
Reported amount sold$8,000,000$5,000,000$-3,000,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001853373-25-000001 · Later SEC source: 0001853373-25-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Aug 12, 2025

Reported offering amount
$10,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$5,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)